161
Participants
Start Date
October 16, 2015
Primary Completion Date
March 21, 2018
Study Completion Date
March 21, 2018
Sirukumab
Sirukumab will be provided as 1 millilitre (mL) Pre-filled Syringe (PFS), containing 100 mg/mL or 50 mg/mL of sirukuma, fitted with a spring-powered, disposable autoinjector device for single use SC administration of liquid biologic drug.
Placebo to match sirukumab
Placebo to match sirukumab will be provided as 1.0 mL PFS fitted with a spring-powered, disposable autoinjector device for single use SC administration of liquid biologic drug.
Prednisone
Prednisone will be provided as tablets with dosage level up to-60 mg/day. The prednisone dose for all subjects will be determined by the Investigator and starting doses will be within 20-60 mg prednisone at Baseline (Randomization).
Placebo to match prednisone
Placebo to match prednisone will be provided as tablets.
GSK Investigational Site, Budapest
GSK Investigational Site, Sofia
GSK Investigational Site, Camperdown
GSK Investigational Site, Kogarah
GSK Investigational Site, Leuven
GSK Investigational Site, Heidelberg
GSK Investigational Site, Malvern East
GSK Investigational Site, Hamilton
GSK Investigational Site, Liège
GSK Investigational Site, Plovdiv
GSK Investigational Site, Debrecen
GSK Investigational Site, Woodville
GSK Investigational Site, Victoria Park
GSK Investigational Site, Timaru
GSK Investigational Site, New York
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, A Coruña
GSK Investigational Site, Philadelphia
GSK Investigational Site, Rozzano
GSK Investigational Site, Milan
GSK Investigational Site, Hamburg
GSK Investigational Site, Hanover
GSK Investigational Site, Boca Raton
GSK Investigational Site, Naples
GSK Investigational Site, Jackson
GSK Investigational Site, San Cristóbal de La Laguna
GSK Investigational Site, Düsseldorf
GSK Investigational Site, Reggio Emilia
GSK Investigational Site, Orléans
GSK Investigational Site, Bilbao
GSK Investigational Site, Iowa City
GSK Investigational Site, Rochester
GSK Investigational Site, Tübingen
GSK Investigational Site, Kirchheim unter Teck
GSK Investigational Site, Paris
GSK Investigational Site, Dallas
GSK Investigational Site, Paris
GSK Investigational Site, Aurora
GSK Investigational Site, München
GSK Investigational Site, Bobigny
GSK Investigational Site, Bad Abbach
GSK Investigational Site, Seattle
GSK Investigational Site, Vancouver
GSK Investigational Site, Boston
GSK Investigational Site, Boston
GSK Investigational Site, Dresden
GSK Investigational Site, Jena
GSK Investigational Site, Almelo
GSK Investigational Site, Groningen
GSK Investigational Site, Nijmegen
GSK Investigational Site, Krakow
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Westcliff-on-Sea
GSK Investigational Site, Metropolitan Borough of Wirral
GSK Investigational Site, Bury St Edmunds
GSK Investigational Site, Sheffield
GSK Investigational Site, Edinburgh
GSK Investigational Site, Leeds
GSK Investigational Site, Oxford
GSK Investigational Site, Reading
Lead Sponsor
GlaxoSmithKline
INDUSTRY